Insmed Financial Statements From 2010 to 2024

INSM Stock  USD 27.25  1.31  4.59%   
Insmed financial statements provide useful quarterly and yearly information to potential Insmed Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Insmed financial statements helps investors assess Insmed's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Insmed's valuation are summarized below:
Gross Profit
190.2 M
Profit Margin
(2.46)
Market Capitalization
B
Enterprise Value Revenue
15.2889
Revenue
305.2 M
There are over one hundred nineteen available fundamental trends for Insmed Inc, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to confirm Insmed's regular fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 13th of April 2024, Market Cap is likely to drop to about 534.3 M. In addition to that, Enterprise Value is likely to drop to about 425.4 M

Insmed Total Revenue

320.47 Million

Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 80.1 M or Total Revenue of 320.5 M, as well as many exotic indicators such as Price To Sales Ratio of 13.55, Dividend Yield of 0.0 or Days Sales Outstanding of 46.8. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.
  
This module can also supplement Insmed's financial leverage analysis and stock options assessment as well as various Insmed Technical models . Check out the analysis of Insmed Correlation against competitors.

Insmed Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B1.3 B635.4 M
Slightly volatile
Other Current Liabilities225.7 M215 M57.4 M
Slightly volatile
Total Current Liabilities236.9 M225.6 M81.6 M
Slightly volatile
Property Plant And Equipment Net109.6 M104.4 M45.9 M
Slightly volatile
Accounts Payable68.7 M65.4 M23.5 M
Slightly volatile
Cash506.5 M482.4 M366.7 M
Slightly volatile
Non Current Assets Total420.8 M400.8 M167.8 M
Slightly volatile
Non Currrent Assets Other101.4 M96.6 M25.6 M
Slightly volatile
Cash And Short Term Investments819.5 M780.4 M416.9 M
Slightly volatile
Common Stock Total Equity804.3 K1.6 M740.1 K
Slightly volatile
Common Stock Shares Outstanding147.5 M140.4 M73.2 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B1.3 B635.4 M
Slightly volatile
Other Current Assets25.4 M24.2 M12.5 M
Slightly volatile
Other Stockholder Equity3.3 B3.1 B1.5 B
Slightly volatile
Total Liabilities1.7 B1.7 B503.4 M
Slightly volatile
Property Plant And Equipment Gross156.5 M149 M52 M
Slightly volatile
Total Current Assets975.5 M929.1 M467.6 M
Slightly volatile
Common Stock837.2 K1.5 M736.9 K
Slightly volatile
Other Liabilities73 M69.6 M22.3 M
Slightly volatile
Other Assets137.3 M130.7 M50.6 M
Slightly volatile
Good Will164.4 M156.5 M78.6 M
Slightly volatile
Non Current Liabilities Total1.5 B1.4 B422 M
Slightly volatile
Intangible Assets61.3 M63.7 M56.9 M
Slightly volatile
Property Plant Equipment68.2 M65 M28.3 M
Slightly volatile
Net Receivables43.2 M41.2 M14.5 M
Slightly volatile
Short Term Debt12.8 M10.6 M15.2 M
Very volatile
Short and Long Term Debt Total1.3 B1.2 B372.3 M
Slightly volatile
Long Term Debt1.2 B1.2 B351 M
Slightly volatile
Capital Surpluse3.4 B3.2 B1.5 B
Slightly volatile
Non Current Liabilities Other254.9 M242.8 M67.1 M
Slightly volatile
Long Term Debt Total1.4 B1.3 B371.7 M
Slightly volatile
Short and Long Term Debt38 M63.9 M41.2 M
Slightly volatile
Net Invested Capital814.8 M823.4 M594.4 M
Slightly volatile
Net Working Capital667.3 M703.4 M488.5 M
Slightly volatile
Capital Stock1.2 M1.5 M942.6 K
Slightly volatile
Capital Lease Obligations41.1 M48.7 M56.5 M
Slightly volatile

Insmed Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating ExpensesB986.1 M343 M
Slightly volatile
Research Development599.6 M571 M184.7 M
Slightly volatile
Total Operating Expenses966.6 M920.6 M323 M
Slightly volatile
Selling General Administrative361.7 M344.5 M135.3 M
Slightly volatile
Selling And Marketing Expenses12.1 M23.9 M19.1 M
Pretty Stable
Interest Income2.1 M2.2 M4.4 M
Very volatile
Reconciled Depreciation10.6 M10.6 M6.5 M
Slightly volatile

Insmed Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow1.1 B1.1 B377.4 M
Slightly volatile
Depreciation11.1 M10.6 M5.7 M
Slightly volatile
Other Non Cash Items94.7 M90.2 M23.1 M
Slightly volatile
Capital Expenditures14 M13.3 M8.4 M
Slightly volatile
End Period Cash Flow506.5 M482.4 M366.7 M
Slightly volatile
Stock Based Compensation78.5 M74.8 M28.2 M
Slightly volatile
Sale Purchase Of Stock181.5 M358.4 M168 M
Slightly volatile
Change To Netincome28.4 M53.2 M28 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio13.5514.259250.3028
Slightly volatile
Days Sales Outstanding46.849.2582408
Slightly volatile
Stock Based Compensation To Revenue0.380.2451.0246
Pretty Stable
EV To Sales15.7916.623543.5557
Slightly volatile
Inventory Turnover1.080.78770.6878
Very volatile
Days Of Inventory On Hand560463769
Slightly volatile
Sales General And Administrative To Revenue1.071.128716.2796
Slightly volatile
Research And Ddevelopement To Revenue1.781.87096.4242
Slightly volatile
Cash Per Share8.25.55745.9172
Pretty Stable
Capex To Operating Cash Flow0.0260.02480.0395
Very volatile
Income Quality0.620.71540.7915
Very volatile
Intangibles To Total Assets0.210.15030.1968
Slightly volatile
Current Ratio3.914.11777.4101
Slightly volatile
Receivables Turnover7.047.40994.3915
Slightly volatile
Graham Number33.2816.847920.8215
Slightly volatile
Revenue Per Share2.282.17331.0103
Slightly volatile
Interest Debt Per Share9.579.11643.6104
Slightly volatile
Debt To Assets0.950.90540.3647
Slightly volatile
Operating Cycle410513889
Slightly volatile
Ebt Per Ebit1.111.05271.0423
Slightly volatile
Long Term Debt To Capitalization1.451.38530.4889
Slightly volatile
Total Debt To Capitalization1.451.38060.4728
Slightly volatile
Quick Ratio3.463.64157.0916
Slightly volatile
Dividend Paid And Capex Coverage Ratio47.6140.355741.5714
Pretty Stable
Net Income Per E B T0.781.00340.973
Pretty Stable
Cash Ratio2.032.13795.5384
Pretty Stable
Days Of Inventory Outstanding560463769
Slightly volatile
Days Of Sales Outstanding46.849.2582408
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.791.02481.0237
Slightly volatile
Fixed Asset Turnover2.782.92382.2642
Pretty Stable
Capital Expenditure Coverage Ratio47.6140.355741.5714
Pretty Stable
Debt Ratio0.950.90540.3647
Slightly volatile
Price Sales Ratio13.5514.259250.3028
Slightly volatile
Asset Turnover0.160.22950.0988
Slightly volatile
Gross Profit Margin0.550.78520.7744
Slightly volatile

Insmed Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap534.3 M907.4 M812.5 M
Slightly volatile

Insmed Fundamental Market Drivers

Cash And Short Term Investments780.4 M

Insmed Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Insmed Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Insmed income statement, its balance sheet, and the statement of cash flows. Insmed investors use historical funamental indicators, such as Insmed's revenue or net income, to determine how well the company is positioned to perform in the future. Although Insmed investors may use each financial statement separately, they are all related. The changes in Insmed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Insmed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Insmed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Insmed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-58.9 M-55.9 M
Total Revenue305.2 M320.5 M
Cost Of Revenue65.6 M38.3 M
Stock Based Compensation To Revenue 0.25  0.38 
Sales General And Administrative To Revenue 1.13  1.07 
Research And Ddevelopement To Revenue 1.87  1.78 
Capex To Revenue(0.04)(0.05)
Revenue Per Share 2.17  2.28 
Ebit Per Revenue(2.33)(2.44)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out the analysis of Insmed Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.34)
Revenue Per Share
2.173
Quarterly Revenue Growth
0.411
Return On Assets
(0.28)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.